![Aeterna Zentaris Inc](/common/images/company/N_AEZS.png)
AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license a... AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license agreement with Novo Nordisk & the company receives royalties on sales. Aeterna owns all rights to macimorelin outside of the U.S. & Canada. It is leveraging the clinical success & safety profile of macimorelin to develop it for the diagnosis of child-onset GHD. The company's geographical segments include Switzerland, Ireland, Denmark, and others, of which nearly all of its revenue comes from Switzerland. Show more
Company expects to report top-line data and complete study results in Q3 2024 TORONTO, ONTARIO, June 13, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (โAeternaโ or...
TORONTO and EDMONTON, Alberta, June 03, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (โAeternaโ or the โCompanyโ) and Ceapro Inc. (TSX-V: CZO) (OTCQX: CRPOF...
TORONTO and EDMONTON, June 03, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (โAeternaโ or the โCompanyโ) and Ceapro Inc. (TSX-V: CZO) (OTCQX: CRPOF) (โCeaproโ), two...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.04 | -0.896860986547 | 4.46 | 4.85 | 4.355 | 3632 | 4.52989675 | CS |
4 | -3.53 | -44.4025157233 | 7.95 | 7.95 | 3.96 | 6225 | 5.55388459 | CS |
12 | -3.86 | -46.6183574879 | 8.28 | 11.1 | 3.96 | 13218 | 8.26020391 | CS |
26 | -3.02 | -40.5913978495 | 7.44 | 11.1 | 3.96 | 15207 | 8.11348145 | CS |
52 | -5.78 | -56.6666666667 | 10.2 | 12.84 | 3.96 | 13272 | 8.59463267 | CS |
156 | 0.98 | 28.488372093 | 3.44 | 23.6 | 0.658 | 456274 | 2.35293854 | CS |
260 | -7.58 | -63.1666666667 | 12 | 23.6 | 0.658 | 1846617 | 4.55257313 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.